Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy

Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy

Abstract Objective To explore the potential of neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) as biomarkers of spinal cord degeneration in adrenoleukodystrophy, as objective treatment‐outcome parameters are needed. Methods Plasma NfL and GFAP levels were measured in 45 male and...

Full description

Bibliographic Details
Main Authors:	Wouter J. C. vanBallegoij, Stephanie I.W. van deStadt, Irene C. Huffnagel, Stephan Kemp, Eline A. J. Willemse, Charlotte E. Teunissen, Marc Engelen
Format:	Article
Language:	English
Published:	Wiley 2020-11-01
Series:	Annals of Clinical and Translational Neurology
Online Access:	https://doi.org/10.1002/acn3.51188

Similar Items

Optical coherence tomography to measure the progression of myelopathy in adrenoleukodystrophy
by: Wouter J. C. vanBallegoij, et al.
Published: (2021-05-01)

Postural Body Sway as Surrogate Outcome for Myelopathy in Adrenoleukodystrophy
by: Wouter J. C. van Ballegoij, et al.
Published: (2020-07-01)

Magnetic resonance spectroscopy as marker for neurodegeneration in X-linked adrenoleukodystrophy
by: Stephanie I.W. van de Stadt, et al.
Published: (2021-01-01)

Disease progression in women with X-linked adrenoleukodystrophy is slow
by: Irene C. Huffnagel, et al.
Published: (2019-02-01)

Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
by: Patrick Schindler, et al.
Published: (2021-05-01)

Overall intact cognitive function in male X-linked adrenoleukodystrophy adults with normal MRI
by: Noortje J. M. L. Buermans, et al.
Published: (2019-09-01)

Bezafibrate for X-linked adrenoleukodystrophy.
by: Marc Engelen, et al.
Published: (2012-01-01)

Adrenoleukodystrophy
by: J Gordon Millichap
Published: (1989-12-01)

Clinical-Pathological Study on Expressions β-APP, GFAP, NFL, Spectrin II, CD68 to Verify Diffuse Axonal Injury Diagnosis, Grade and Survival Interval
by: Ciocoiu, M., et al.
Published: (2022)

Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study
by: Afonso, S., et al.
Published: (2022)

Adrenoleukodystrophy
by: Nišić Tatjana, et al.
Published: (2016-01-01)

Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor
by: Rinse W. Barendsen, et al.
Published: (2020-06-01)

Corrigendum: Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor
by: Rinse W. Barendsen, et al.
Published: (2021-01-01)

X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management
by: Engelen Marc, et al.
Published: (2012-08-01)

Running Backs in the NFL Draft and NFL Combine: Can Performance be Predicted?
by: Blees, Chris
Published: (2011)

Multi-Omic Approach to Identify Phenotypic Modifiers Underlying Cerebral Demyelination in X-Linked Adrenoleukodystrophy
by: Phillip A. Richmond, et al.
Published: (2020-06-01)

C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man.
by: Malu-Clair van de Beek, et al.
Published: (2016-01-01)

Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MS
by: Anderson, M., et al.
Published: (2022)

Prognosis of X-Linked Adrenoleukodystrophy
by: J Gordon Millichap
Published: (2005-08-01)

Genetics of X-Linked Adrenoleukodystrophy
by: J Gordon Millichap
Published: (2002-08-01)

Bone Marrow Transplant in Adrenoleukodystrophy
by: J Gordon Millichap
Published: (1997-07-01)

Lorenzo Oil Therapy for Adrenoleukodystrophy
by: J Gordon Millichap
Published: (1993-08-01)

A Better Predictor of NFL Success: Collegiate Performance or the NFL Draft Combine?
by: Gallagher, Michael
Published: (2019)

The Law and Economics of Monopsony in the NFL: An Analysis of the NFL Rookie Draft and Countervailing Force
by: Pyle, Benjamin D
Published: (2013)

The Role of Serum Levels of Neurofilament Light (NfL) Chain as a Biomarker in Friedreich Ataxia
by: Bernice Frempong, et al.
Published: (2021-03-01)

Correlational Analysis of ALS Progression and Serum NfL Measured by Simoa Assay in Chinese Patients
by: Kazuo Sugimoto, et al.
Published: (2020-12-01)

NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study
by: Timo Uphaus, et al.
Published: (2021-10-01)

Combined use of CSF NfL and CSF TDP‐43 improves diagnostic performance in ALS
by: Takashi Kasai, et al.
Published: (2019-12-01)

Dystonia and adrenoleukodystrophy: an overview
by: Jamir Pitton Rissardo, et al.
Published: (2020-01-01)

Childhood cerebral adrenoleukodystrophy
by: Aliza Mittal, et al.
Published: (2014-01-01)

GFAP at 50
by: Albee Messing, et al.
Published: (2020-08-01)

Evaluating NFL Player Performance and Draft Efficiency: Where is the Best Value in the NFL Draft?
by: Lee, Justin
Published: (2018)

Infantile Spasms, Hypsarrhythmia, and Adrenoleukodystrophy (ALD)
by: J Gordon Millichap
Published: (1988-08-01)

Adrenoleukodystrophy: Childhood and Adult Forms Compared
by: J Gordon Millichap
Published: (1991-07-01)

Newborn Screening for X-Linked Adrenoleukodystrophy
by: Ann B. Moser, et al.
Published: (2016-12-01)

Life Planning for NFL Players
by: Pedersen, Ryan
Published: (2011)

The NFL true fan problem
by: Whittle, Scott
Published: (2014)

Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: Implications for X-linked adrenoleukodystrophy
by: Romana Höftberger, et al.
Published: (2007-11-01)

The Journey Through No-Man's Land: A Phenomenological Study of NFL Free-Agent Players' Transition Experience from Active NFL Player to Retired NFL Player
by: Davis, Donald E., Jr.
Published: (2021)

A Score Based on NfL and Glial Markers May Differentiate Between Relapsing–Remitting and Progressive MS Course
by: André Huss, et al.
Published: (2020-07-01)